Peter Gohlke

5.4k total citations · 1 hit paper
95 papers, 4.5k citations indexed

About

Peter Gohlke is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Peter Gohlke has authored 95 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Cardiology and Cardiovascular Medicine, 36 papers in Molecular Biology and 22 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Peter Gohlke's work include Renin-Angiotensin System Studies (44 papers), Hormonal Regulation and Hypertension (21 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (21 papers). Peter Gohlke is often cited by papers focused on Renin-Angiotensin System Studies (44 papers), Hormonal Regulation and Hypertension (21 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (21 papers). Peter Gohlke collaborates with scholars based in Germany, United Kingdom and United States. Peter Gohlke's co-authors include Thomas Unger, Juraj Čulman, Wolfgang Linz, Bernward A. Schölkens, Gabriele Wiemer, Yi Zhao, T Unger, Thomas Herdegen, Christiane Pees and Annegret Blume and has published in prestigious journals such as Diabetes, Stroke and Brain Research.

In The Last Decade

Peter Gohlke

93 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.

1995 551 citations Wolfgang Linz, Gabriele Wiemer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Gohlke Germany	37	2.5k	1.5k	1.1k	734	632	95	4.5k
U. Muscha Steckelings Germany	45	3.8k 1.5×	2.3k 1.5×	2.0k 1.8×	384 0.5×	487 0.8×	133	5.9k
Toshihiro Ichiki Japan	46	3.5k 1.4×	3.4k 2.3×	2.1k 1.9×	371 0.5×	1.1k 1.7×	111	7.4k
Masaki Mogi Japan	43	2.1k 0.9×	1.9k 1.3×	1.3k 1.2×	161 0.2×	997 1.6×	179	5.4k
Gabriele Wiemer Germany	33	2.2k 0.9×	1.1k 0.8×	895 0.8×	1.2k 1.6×	1.2k 1.9×	76	4.2k
Volkmar Groß Germany	32	1.3k 0.5×	1.3k 0.9×	926 0.9×	184 0.3×	674 1.1×	64	3.6k
Robert H. G. Schwinger Germany	44	4.0k 1.6×	3.5k 2.4×	417 0.4×	465 0.6×	527 0.8×	203	6.5k
Laurent Loufrani France	36	1.0k 0.4×	1.8k 1.2×	609 0.6×	201 0.3×	1.1k 1.7×	92	3.7k
Khalid Matrougui United States	40	972 0.4×	1.6k 1.1×	547 0.5×	179 0.2×	963 1.5×	90	4.1k
Robert Gros Canada	37	1.0k 0.4×	2.1k 1.4×	1.0k 1.0×	108 0.1×	818 1.3×	94	4.2k
Li‐Juan Min Japan	34	1.2k 0.5×	1.1k 0.7×	951 0.9×	90 0.1×	587 0.9×	67	2.9k

Countries citing papers authored by Peter Gohlke

Since Specialization

Citations

This map shows the geographic impact of Peter Gohlke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Gohlke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Gohlke more than expected).

Fields of papers citing papers by Peter Gohlke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Gohlke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Gohlke. The network helps show where Peter Gohlke may publish in the future.

Co-authorship network of co-authors of Peter Gohlke

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Gohlke. A scholar is included among the top collaborators of Peter Gohlke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Gohlke. Peter Gohlke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Yi, et al.. (2015). Omapatrilat: penetration across the blood–brain barrier and effects on ischaemic stroke in rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 388(9). 939–951.

Glatz, Torben, et al.. (2010). Peroxisome-proliferator-activated receptors γ and peroxisome-proliferator-activated receptors β/δ and the regulation of interleukin 1 receptor antagonist expression by pioglitazone in ischaemic brain. Journal of Hypertension. 28(7). 1488–1497. 50 indexed citations

Kaiser, Sabine, et al.. (2006). Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke. Journal of Hypertension. 25(1). 187–196. 34 indexed citations

Zhao, Yi, Andreas Patzer, Peter Gohlke, Thomas Herdegen, & Juraj Čulman. (2005). The intracerebral application of the PPARγ‐ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain. European Journal of Neuroscience. 22(1). 278–282. 84 indexed citations

Day, Stephen H., Craig A. Williams, Jonathan P. Folland, Peter Gohlke, & Alun G. Williams. (2004). The acute effects of exercise and glucose ingestion on circulating angiotensin-converting enzyme in humans. European Journal of Applied Physiology. 92(4-5). 579–83. 4 indexed citations

Pees, Christiane, Thomas Unger, & Peter Gohlke. (2003). Effect of angiotensin AT2 receptor stimulation on vascular cyclic GMP production in normotensive Wistar Kyoto rats. The International Journal of Biochemistry & Cell Biology. 35(6). 963–972. 15 indexed citations

Gohlke, Peter, et al.. (2002). Effects of orally applied candesartan cilexetil on central responses to angiotensin II in conscious rats. Journal of Hypertension. 20(5). 909–918. 50 indexed citations

Datté, Jacques Yao, et al.. (2001). AT RECEPTOR INHIBITION AFFECTS THE NORADRENALINE SENSITIVITY IN ISOLATED PORTAL VEIN OF NORMOTENSIVE RAT. Clinical and Experimental Hypertension. 23(3). 177–187. 4 indexed citations

Gohlke, Peter, Anita Jansen, Wolfgang Wienen, et al.. (2001). AT1 Receptor Antagonist Telmisartan Administered Peripherally Inhibits Central Responses to Angiotensin II in Conscious Rats. Journal of Pharmacology and Experimental Therapeutics. 298(1). 62–70. 115 indexed citations

10.

Pinto, Y M, et al.. (1998). A 40-fold increase in cardiac angiotensin converting enzyme activity fails to increase local angiotensin II concentrations.. Data Archiving and Networked Services (DANS). 4 indexed citations

11.

Montgomery, Hugh, Caroline Whitworth, Stewart Fleming, et al.. (1998). Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN2)27. Journal of Hypertension. 16(5). 635–643. 44 indexed citations

12.

Zhu, Yi‐Chun, Harald M. Stauss, Gang Bao, et al.. (1995). Role of bradykinin in the antihypertensive and cardioprotective actions of converting enzyme inhibitors. Canadian Journal of Physiology and Pharmacology. 73(7). 827–831. 10 indexed citations

13.

Linz, Wolfgang, et al.. (1994). [Cardioprotective effects by ramipril after ischemia and reperfusion in animal experiment studies].. PubMed. 83 Suppl 4. 53–6.

14.

Tschöpe, Carsten, Monika Stoll, Peter Gohlke, & Thomas Unger. (1994). Potential effects of bradykinin on myocardial capillary growth after angiotensin converting enzyme inhibition. Expert Opinion on Investigational Drugs. 3(5). 501–510. 3 indexed citations

15.

Unger, Thomas & Peter Gohlke. (1994). Converting enzyme inhibitors in cardiovascular therapy: current status and future potential. Cardiovascular Research. 28(2). 146–158. 47 indexed citations

16.

Obermüller, Nicholas, Thomas Unger, Juraj Čulman, et al.. (1991). Distribution of angiotensin II receptor subtypes in rat brain nuclei. Neuroscience Letters. 132(1). 11–15. 88 indexed citations

17.

Veltmar, Annette, Peter Gohlke, & Thomas Unger. (1991). From Tissue Angiotensin Converting Enzyme Inhibition to Antihypertensive Effect. American Journal of Hypertension. 4(3_Pt_2). 263S–269S. 7 indexed citations

18.

Bao, Gang, et al.. (1991). HOE 140, a new highly potent and long-acting bradykinin antagonist in conscious rats. European Journal of Pharmacology. 200(1). 179–182. 56 indexed citations

19.

Gohlke, Peter, et al.. (1989). Inhibition of converting enzyme in the cerebrospinal fluid of rats after oral treatment with converting enzyme inhibitors.. Journal of Pharmacology and Experimental Therapeutics. 249(2). 609–616. 26 indexed citations

20.

Unger, Thomas, et al.. (1989). Angiotensin II and atrial natriuretic peptide in the brain: Effects on volume and Na+ balance. Resuscitation. 18(2-3). 309–319. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact